e-learning
resources
Milan 2017
Sunday, 10.09.2017
Interstitial lung diseases (ILDs): novel pathogenetic pathways
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2017 - Hippo-YAP/TAZ signaling is deranged in IPF
D. Wagner (Lund, Sweden)
Source:
International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways
Session:
Interstitial lung diseases (ILDs): novel pathogenetic pathways
Session type:
Oral Presentation
Number:
475
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Wagner (Lund, Sweden). LSC - 2017 - Hippo-YAP/TAZ signaling is deranged in IPF. 475
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
LSC - 2020 - GCN2 signalling is dysregulated in pulmonary fibrosis
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017
LSC - 2017 - Targeting glucose metabolism in experimental lung injury and fibrosis
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
LSC - 2019 - Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma and COPD
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017
LSC - 2021 - SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021
LSC - 2018 - Physical and biochemical interactions drive fibrocytes accumulation in the scleroderma lung matrix
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
LSC - 2020 - The transcriptome of IPF fibrotic foci identifies the fatty acid metabolism as a critical pathway in fibrogenesis
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
LSC - 2018 - Distinct metabolic alterations in airway macrophages during pulmonary fibrosis
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
LSC - 2018 - Collagen-producing macrophages can mediate lung fibrosis throughFra-2/AP-1 expression
Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology
Year: 2018
LSC - 2021 - Club cell functions as a Wnt-responsive progenitor for tissue repair in COPD
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021
LSC - 2021 - A comprehensive guide to pulmonary mesenchymal populations in the healthy and IPF lung.
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021
LSC - 2019 - STAT-3 is activated in COPD airway epithelial cells.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Year: 2019
LSC - 2021 - Regulation of PA200 in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
LSC - 2020 - IRF5 regulates airway macrophage metabolic responses to viral challenge
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
LSC - 2018 - Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
LSC - 2019 - Sputum protein profiling identifies a key role for neutrophil extracellular traps in exacerbations of bronchiectasis and treatment response
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
LSC - 2019 - Dysfunctional macrophage polarization in murine COPD exacerbation
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept